These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9870840)

  • 1. Thyroid disease mediated by molecular defects in cell surface and nuclear receptors.
    Bodenner DL; Lash RW
    Am J Med; 1998 Dec; 105(6):524-38. PubMed ID: 9870840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to thyroid hormone in a patient without thyroid hormone receptor mutations.
    Parikh S; Ando S; Schneider A; Skarulis MC; Sarlis NJ; Yen PM
    Thyroid; 2002 Jan; 12(1):81-6. PubMed ID: 11838736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [TSH receptors and signal transduction].
    Kawakami Y; Fujita R; Okuda Y; Yamashita K
    Nihon Rinsho; 1993 Oct; 51(10):2649-54. PubMed ID: 8254934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear corepressors enhance the dominant negative activity of mutant receptors that cause resistance to thyroid hormone.
    Tagami T; Jameson JL
    Endocrinology; 1998 Feb; 139(2):640-50. PubMed ID: 9449636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible binding site of thyrotropin binding inhibitor immunoglobulin (TBII) on the thyrotropin (TSH) receptor, which is different from TSH binding site.
    Piraphatdist T; Sugawa H; Inoue D; Enomoto T; Mori T; Imura H
    Biochem Biophys Res Commun; 1990 Oct; 172(2):529-36. PubMed ID: 1978673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel thyroid hormone receptor-beta mutation that fails to bind nuclear receptor corepressor in a patient as an apparent cause of severe, predominantly pituitary resistance to thyroid hormone.
    Wu SY; Cohen RN; Simsek E; Senses DA; Yar NE; Grasberger H; Noel J; Refetoff S; Weiss RE
    J Clin Endocrinol Metab; 2006 May; 91(5):1887-95. PubMed ID: 16464943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular biology of thyroid diseases].
    Nagy E; Mezösi E; Leövey A
    Orv Hetil; 1996 Mar; 137(11):563-8. PubMed ID: 8721579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominant inheritance of resistance to thyroid hormone not linked to defects in the thyroid hormone receptor alpha or beta genes may be due to a defective cofactor.
    Weiss RE; Hayashi Y; Nagaya T; Petty KJ; Murata Y; Tunca H; Seo H; Refetoff S
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4196-203. PubMed ID: 8954015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G-protein-coupled receptors in endocrine disease.
    Pearce SH; Trump D
    QJM; 1995 Jan; 88(1):3-8. PubMed ID: 7894986
    [No Abstract]   [Full Text] [Related]  

  • 10. Thyroid disease mediated by molecular defects in cell surface and nuclear receptors.
    Khardori R; Al-Sharafi B; Abraham M
    Am J Med; 1999 Oct; 107(4):407. PubMed ID: 10527053
    [No Abstract]   [Full Text] [Related]  

  • 11. Pituitary resistance to thyroid hormone syndrome is associated with T3 receptor mutants that selectively impair beta2 isoform function.
    Wan W; Farboud B; Privalsky ML
    Mol Endocrinol; 2005 Jun; 19(6):1529-42. PubMed ID: 15802373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TSH receptor and thyroid-specific gene expression in human skin.
    Cianfarani F; Baldini E; Cavalli A; Marchioni E; Lembo L; Teson M; Persechino S; Zambruno G; Ulisse S; Odorisio T; D'Armiento M
    J Invest Dermatol; 2010 Jan; 130(1):93-101. PubMed ID: 19641516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A familial thyrotropin (TSH) receptor mutation provides in vivo evidence that the inositol phosphates/Ca2+ cascade mediates TSH action on thyroid hormone synthesis.
    Grasberger H; Van Sande J; Hag-Dahood Mahameed A; Tenenbaum-Rakover Y; Refetoff S
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2816-20. PubMed ID: 17456567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to thyroid hormone due to mutations in the THRB gene impairs bone mass and affects calcium and phosphorus homeostasis.
    Cardoso LF; de Paula FJ; Maciel LM
    Bone; 2014 Oct; 67():222-7. PubMed ID: 25063548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thyroid hormone resistance: variable clinical manifestations in five patients].
    Reinhardt W; Jockenhövel F; Deuble J; Chatterjee VK; Reinwein D; Mann K
    Nuklearmedizin; 1997 Oct; 36(7):250-5. PubMed ID: 9441285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene.
    Pohlenz J; Weiss RE; Macchia PE; Pannain S; Lau IT; Ho H; Refetoff S
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3919-28. PubMed ID: 10566629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The posttranslational modification of thyrotropin receptor and thyroid diseases].
    Adler G
    Endokrynol Pol; 2005; 56(1):72-7. PubMed ID: 16335676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear binding of [125I]triiodothyronine in dispersed cultured skin fibroblasts from patients with resistance to thyroid hormone.
    Eil C; Fein HG; Smith TJ; Furlanetto RW; Bourgeois M; Stelling MW; Weintraub BD
    J Clin Endocrinol Metab; 1982 Sep; 55(3):502-10. PubMed ID: 6284781
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor.
    Kosugi S; Ban T; Kohn LD
    Mol Endocrinol; 1993 Jan; 7(1):114-30. PubMed ID: 8095322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and characterization of a corepressor and potential component of the nuclear hormone receptor repression complex.
    Zamir I; Dawson J; Lavinsky RM; Glass CK; Rosenfeld MG; Lazar MA
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14400-5. PubMed ID: 9405624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.